[A few years of following up results of chronic respiratory infections with broncho-vaxom].
Broncho-Vaxom was administered to 57 patients with chronic respiratory infections. A significant improvement was noted in 70% of the treated patients whereas mild improvement in 21%. Discussing the results of Broncho-Vaxom therapy, the author suggests so-called maintenance therapy with the same preparation to stabilize its effect.
Polubiec
A
A
Katedry i Kliniki Chorób Wewnetrznych i Hematologii II Wydziału Lekarskiego AM w Warszawie.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001419:Bacteria; D002457:Cell Extracts; D002908:Chronic Disease; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D000095983:Bacterial Lysates
D000276:Adjuvants, Immunologic; D002457:Cell Extracts; C030259:Broncho-Vaxom; D000095983:Bacterial Lysates
Kilkuletnia obserwacja dotyczaca wyników leczenia przewlekłych zakazeń dróg oddechowych preparatem Broncho-Vaxom.